NCT05848687 TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II Status RECRUITING Phase PHASE1/PHASE2
NCT05826756 Project PEER: Understanding the Lung Cancer Patient ExperiEnce in the Real-World Setting Status RECRUITING Phase N/A
NCT05800964 Study to Explore the Safety, Tolerability, and Pharmacokinetics of AMG 305 in Subjects With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT05789303 Study of Belantamab Mafodotin With Carfilzomib, Pomalidomide, and Dexamethasone in Relapsed Multiple Myeloma Status RECRUITING Phase PHASE2
NCT05767047 A Study of Apremilast in Children With Oral Ulcers Associated With Behçet's Disease or Juvenile Psoriatic Arthritis Status RECRUITING Phase PHASE3
NCT05740566 Study Comparing Tarlatamab With Standard of Care Chemotherapy in Relapsed Small Cell Lung Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05724199 A Study Assessing Rocatinlimab in Combination With Topical Corticosteroid and/or Topical Calcineurin Inhibitors in Adult Participants With Moderate-to-severe Atopic Dermatitis (AD) Status COMPLETED Phase PHASE3
NCT05704738 A Study to Evaluate Rocatinlimab (AMG 451) in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD) Status COMPLETED Phase PHASE3
NCT05704725 A Study to Evaluate ABP 938 and Aflibercept (Eylea®) in Participants With Chorioretinal Vascular Disease (CVD) Status COMPLETED Phase PHASE3
NCT05672199 Long-term Safety and Efficacy of Efavaleukin Alfa in Participants With Moderately to Severely Active Ulcerative Colitis Status TERMINATED Phase PHASE2
NCT05669599 Dose-ranging Study to Evaluate the Efficacy, Safety, and Tolerability of AMG 133 in Adult Subjects With Overweight or Obesity, With or Without Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE2
NCT05669040 mHealth to Improve the Experience, Adherence to Drug Treatment and Positive Mental Health Status UNKNOWN Phase NA
NCT05669014 A Phase 2 Proof of Concept Study to Evaluate the Efficacy and Safety of Daxdilimab in Participants With Dermatomyositis (DM) or Anti-synthetase Inflammatory Myositis (ASIM) Status COMPLETED Phase PHASE2
NCT05651711 A Study Assessing Rocatinlimab (AMG 451) Monotherapy in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Horizon) Status COMPLETED Phase PHASE3
NCT05633355 A Study to Assess the Safety, Tolerability, and Efficacy of Rocatinlimab in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD) Status COMPLETED Phase PHASE3
NCT05626751 An Open-label Extension Trial of HZNP-HZN-825-301 in Adult Participants With Diffuse Cutaneous Systemic Sclerosis (Diffuse Cutaneous SSc) Status TERMINATED Phase PHASE2
NCT05599828 A Study to Evaluate the Impact of Acid-reducing Agents on the Pharmacokinetics (PK) of AMG 510 in Healthy Participants Status COMPLETED Phase PHASE1
NCT05598281 Study to Evaluate the Effect of AMG 510 on the Pharmacokinetics (PK) of Digoxin in Healthy Participants Status COMPLETED Phase PHASE1
NCT05591222 Study of Daxdilimab (HZN-7734) in Participants With Moderate-to-Severe Primary Discoid Lupus Erythematosus Status TERMINATED Phase PHASE2